Table 1 Demographics and clinical characteristics of severe COVID-19
From: Cardiac damage in patients with the severe type of coronavirus disease 2019 (COVID-19)
Variables | Median (IQR), or N (%) |
|---|---|
Patients (n = 100) | |
Age, y | |
Median (IQR) | 62.0 (51.0–70.8) |
< 60 | 40 (40.0) |
≥ 60 | 60 (60.0) |
Sex | |
Male | 56 (56.0) |
Female | 44 (44.0) |
Comorbidities | 69 (69.0) |
Hypertension | 40 (40.0) |
Diabetes | 21 (21.0) |
CVD | 15 (15.0) |
COPD | 12 (12.0) |
Malignancy | 13 (13.0) |
Hypothyroidism | 2 (2.0) |
Liver cirrhosis | 3 (3.0) |
Hyperlipidemia | 2 (2.0) |
Anemia | 2 (2.0) |
Initial symptoms | |
Fever | 69 (69.0) |
Cough | 63 (63.0) |
Chest distress | 13 (13.0) |
Fatigue | 12 (12.0) |
Sputum | 7 (7.0) |
Myalgia | 5 (5.0) |
Dyspnea | 6 (6.0) |
Headache | 4 (4.0) |
Sore throat | 4 (4.0) |
Chest pain | 2 (2.0) |
Diarrhea | 3 (3.0) |
Nausea | 3 (3.0) |
SBP, mmHg | 135.0 (122.0–149.0) |
DBP, mmHg | 81.5 (74.8–91.0) |
Heart rate, bpm | 92.5 (79.5–103.3) |
SPO2, %§ | 97.0 (95.0–98.0) |
≤ 93.0 | 10 (10.0) |
Days from illness onset to admission | 14.0 (7.0–28.0) |
Hospitalization time, day | 21.0 (15.0–39.5) |